Steroid Dosing and Tapering Regimen for Bell's Palsy
For Bell's palsy, oral prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days followed by a 5-day taper should be prescribed within 72 hours of symptom onset to maximize facial nerve recovery. 1
Recommended Steroid Regimen
- Prednisolone 50 mg daily for 10 days (no taper) 1, 2
- OR
- Prednisone 60 mg daily for 5 days followed by a 5-day taper 1, 3
Timing of Treatment
- Steroids must be initiated within 72 hours of symptom onset for maximum effectiveness 1, 4
- Treatment started within this window shows significantly better outcomes (83% recovery at 3 months with prednisolone vs 63.6% with placebo) 1
- Starting treatment after 72 hours provides minimal benefit and exposes patients to medication risks 4
Evidence for Effectiveness
- Strong evidence supports early corticosteroid use, with 94.4% recovery at 9 months with prednisolone vs 81.6% with placebo 1, 5
- The number needed to treat (NNT) to achieve one additional complete recovery is 6 5
- Single-dose intravenous methylprednisolone (500 mg) has shown similar effectiveness to oral prednisolone in some studies 6
Special Populations Considerations
Children
- Children have higher rates of spontaneous recovery than adults 1, 7
- Evidence for steroid use in children is less conclusive 1, 7
- A recent randomized controlled trial showed no significant improvement with prednisolone in children at 1 month, though the study was underpowered 7
Pregnant Women
- Treatment should be administered within 72 hours of symptom onset 1
- Careful individualized assessment of benefits and risks is necessary 1
Follow-up and Monitoring
- Most patients begin showing signs of recovery within 2-3 weeks of symptom onset 1
- Complete recovery typically occurs within 3-4 months for most patients 1
- Patients should be reassessed or referred to a facial nerve specialist if they have:
Common Pitfalls to Avoid
- Delaying treatment beyond 72 hours significantly reduces effectiveness 4
- Using antiviral therapy alone is ineffective and not recommended 1, 2
- Failing to provide adequate eye protection for patients with impaired eye closure can lead to corneal damage 1
- Not referring patients with incomplete recovery after 3 months for specialist evaluation 1